WallStreetZenWallStreetZen

NASDAQ: GLSI
Greenwich Lifesciences Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for GLSI

Based on 1 analyst offering 12 month price targets for Greenwich Lifesciences Inc.
Min Forecast
$78.00+782.35%
Avg Forecast
$78.00+782.35%
Max Forecast
$78.00+782.35%

Should I buy or sell GLSI stock?

Based on 1 analyst offering ratings for Greenwich Lifesciences Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their GLSI stock forecasts and price targets.

Forecast return on equity

Is GLSI forecast to generate an efficient return?
Company
-50.63%
Industry
-12.12%
Market
98.76%
GLSI's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GLSI forecast to generate an efficient return on assets?
Company
-49.96%
Industry
-5.22%
GLSI is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GLSI earnings per share forecast

What is GLSI's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.71
Avg 2 year Forecast
-$0.67

GLSI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLSI$8.84$78.00+782.35%Strong Buy
XBIT$3.72N/AN/A
ENOB$2.15N/AN/A
PRAX$2.50$10.67+326.68%Buy
VACC$3.07$19.33+529.74%Strong Buy

Greenwich Lifesciences Stock Forecast FAQ

Is Greenwich Lifesciences Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: GLSI) stock is to Strong Buy GLSI stock.

Out of 1 analyst, 1 (100%) are recommending GLSI as a Strong Buy, 0 (0%) are recommending GLSI as a Buy, 0 (0%) are recommending GLSI as a Hold, 0 (0%) are recommending GLSI as a Sell, and 0 (0%) are recommending GLSI as a Strong Sell.

If you're new to stock investing, here's how to buy Greenwich Lifesciences stock.

What is GLSI's earnings growth forecast for 2022-2023?

(NASDAQ: GLSI) Greenwich Lifesciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 18.71%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 46.52%.

Greenwich Lifesciences's earnings in 2022 is -$5,939,524.On average, 1 Wall Street analyst forecast GLSI's earnings for 2022 to be -$9,104,836, with the lowest GLSI earnings forecast at -$9,104,836, and the highest GLSI earnings forecast at -$9,104,836.

In 2023, GLSI is forecast to generate -$8,591,888 in earnings, with the lowest earnings forecast at -$8,591,888 and the highest earnings forecast at -$8,591,888.

What is GLSI's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: GLSI) forecast ROE is -50.63%, which is considered weak.

What is GLSI's Price Target?

According to 1 Wall Street analyst that have issued a 1 year GLSI price target, the average GLSI price target is $78.00, with the highest GLSI stock price forecast at $78.00 and the lowest GLSI stock price forecast at $78.00.

The Wall Street analyst predicted that Greenwich Lifesciences's share price could reach $78.00 by Jul 12, 2023. The average Greenwich Lifesciences stock price prediction forecasts a potential upside of 782.35% from the current GLSI share price of $8.84.

What is GLSI's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: GLSI) Greenwich Lifesciences's current Earnings Per Share (EPS) is -$0.46. On average, analysts forecast that GLSI's EPS will be -$0.71 for 2022, with the lowest EPS forecast at -$0.71, and the highest EPS forecast at -$0.71. In 2023, GLSI's EPS is forecast to hit -$0.67 (min: -$0.67, max: -$0.67).

What is GLSI's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: GLSI) forecast ROA is -49.96%, which is lower than the forecast US Biotechnology industry average of -5.22%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.